Oncotarget has Two of the Best Chief Editors in the Business

Oncotarget is a medical journal released weekly for peer reviewed open access. The publication specializes in covering research pertaining to all aspects of oncology. Since being founded in 2010 it has grown exponentially. By 2011, it earned the rank as the number one journal by Thomson Reuters JCR Impact Factor standards. It has held that ranking into 2017 which shows how great the journal is. People can check out the journal via social media sites Facebook, Twitter, YouTube, LinkedIn and Google +.

Oncotarget’s rise to the top is due in no small part to its chief editors Andrei V. Gudkov and Mikhail Blagosklonny who both happen to work at Roswell Park Institute. The dual editors-in-chief have worked hard to make the journal as diversified as possible. At the start Oncotarget only covered research that helped move oncology forward, but in recent years it’s begun covering cardiology, microbiology, pharmacology and neuroscience. Both Gudkov and Blagosklonny aren’t afraid to try new things and that translates through Oncotarget’s content. Learn more about Oncotarget at Research Gate.

The journal’s first published study was about the relationship between e-cigarettes and gum tissue. An e-cigarette is a handheld battery operated device that creates an aerosol when heating a liquid. The study came at a great time considering how popular e-cigarettes have gotten recently.

What the results of the study showed was that e-cigarettes can cause oral damage if used often for a long period of time. Though it produces aerosol and not tobacco smoke, the liquid inside often contains harmful chemicals that can lead to cancer or other diseases. Check Oncotarget journal at scimagojr.com